Skip to main content
Clinical Trials/TCTR20190707003
TCTR20190707003
Completed
Phase 4

Prevalence, risk factors and clinical characteristics of lipohypertrophy in insulin-treated patients with diabetes

Theptarin Hospital0 sites400 target enrollmentJuly 7, 2019

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
&#45
Sponsor
Theptarin Hospital
Enrollment
400
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 7, 2019
End Date
May 1, 2019
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \-Insulin treated DM patients (both T1DM and T2DM) who are regularly F/U at Theptarin Hospital at least 3 times per year
  • \-Continuation of insulin treatment at least 6 months

Exclusion Criteria

  • \- Non\-insulin treated DM patients
  • \- Use of insulin less than 6 months
  • \- Irregular or lost to F/U patients

Outcomes

Primary Outcomes

Not specified

Similar Trials